FGH BIOTECH Trademark

Trademark Overview

On Tuesday, April 13, 2021, a trademark application was filed for FGH BIOTECH with the United States Patent and Trademark Office. The USPTO has given the FGH BIOTECH trademark a serial number of 90643231. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, September 17, 2024. This trademark is owned by FGH Biotech, Inc.. The FGH BIOTECH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of metabolic diseases and disorders, cancers, immunodeficiencies, viral infections, obesity, skin disorders, psoriasis, atopic dermatitis, gland disorders, Meibomian gland dysfunction, dry eye disease, arthritis, and rheumatoid arthritis
fgh biotech

General Information

Serial Number90643231
Word MarkFGH BIOTECH
Filing DateTuesday, April 13, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, September 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 1, 2022

Trademark Statements

Description of MarkThe mark consists of the wording "FGH BIOTECH" near a stylized hexagon design.
Goods and ServicesPharmaceuticals for the treatment of metabolic diseases and disorders, cancers, immunodeficiencies, viral infections, obesity, skin disorders, psoriasis, atopic dermatitis, gland disorders, Meibomian gland dysfunction, dry eye disease, arthritis, and rheumatoid arthritis
NOT AVAILABLE"BIOTECH"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFGH Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77060
Party NameFGH Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77060

Trademark Events

Event DateEvent Description
Friday, April 16, 2021NEW APPLICATION ENTERED
Wednesday, July 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 22, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 2, 2021ASSIGNED TO EXAMINER
Wednesday, December 15, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 15, 2021NON-FINAL ACTION E-MAILED
Wednesday, December 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 21, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, December 21, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 21, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, December 21, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 21, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, December 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 21, 2021ASSIGNED TO LIE
Tuesday, December 28, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 28, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, December 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 28, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, December 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 29, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 29, 2022SOU EXTENSION 1 FILED
Monday, August 29, 2022SOU EXTENSION 1 GRANTED
Wednesday, August 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 24, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 24, 2023SOU EXTENSION 2 FILED
Friday, March 24, 2023SOU EXTENSION 2 GRANTED
Tuesday, March 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 17, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 17, 2023SOU EXTENSION 3 FILED
Thursday, August 17, 2023SOU EXTENSION 3 GRANTED
Saturday, August 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2024SOU EXTENSION 4 FILED
Tuesday, March 12, 2024SOU EXTENSION 4 GRANTED
Thursday, March 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 17, 2024SOU EXTENSION 5 GRANTED
Tuesday, September 17, 2024SOU EXTENSION 5 FILED
Tuesday, September 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

biotech disorders gland arthritis dermatitis atopic meibomian dysfunction disease psoriasis rheumatoid